| SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function ES Winkler, AL Bailey, NM Kafai, S Nair, BT McCune, J Yu, JM Fox, ... Nature immunology 21 (11), 1327-1335, 2020 | 952 | 2020 |
| Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease NR West, AN Hegazy, BMJ Owens, SJ Bullers, B Linggi, S Buonocore, ... Nature medicine 23 (5), 579-589, 2017 | 753 | 2017 |
| Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis BA Johnson, X Xie, AL Bailey, B Kalveram, KG Lokugamage, A Muruato, ... Nature 591 (7849), 293-299, 2021 | 682 | 2021 |
| Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift SE Hensley, SR Das, AL Bailey, LM Schmidt, HD Hickman, A Jayaraman, ... Science 326 (5953), 734-736, 2009 | 573 | 2009 |
| A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2 AO Hassan, NM Kafai, IP Dmitriev, JM Fox, BK Smith, IB Harvey, RE Chen, ... Cell 183 (1), 169-184. e13, 2020 | 566 | 2020 |
| A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies AO Hassan, JB Case, ES Winkler, LB Thackray, NM Kafai, AL Bailey, ... Cell 182 (3), 744-753. e4, 2020 | 550 | 2020 |
| The antigenic anatomy of SARS-CoV-2 receptor binding domain W Dejnirattisai, D Zhou, HM Ginn, HME Duyvesteyn, P Supasa, JB Case, ... Cell 184 (8), 2183-2200. e22, 2021 | 391 | 2021 |
| Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection ES Winkler, P Gilchuk, J Yu, AL Bailey, RE Chen, Z Chong, SJ Zost, ... Cell 184 (7), 1804-1820. e16, 2021 | 352 | 2021 |
| Reorganization and expansion of the nidoviral family Arteriviridae JH Kuhn, M Lauck, AL Bailey, AM Shchetinin, TV Vishnevskaya, Y Bào, ... Archives of virology 161, 755-768, 2016 | 322 | 2016 |
| Growth, detection, quantification, and inactivation of SARS-CoV-2 JB Case, AL Bailey, AS Kim, RE Chen, MS Diamond Virology 548, 39-48, 2020 | 253 | 2020 |
| SARS-CoV-2 infects human engineered heart tissues and models COVID-19 myocarditis AL Bailey, O Dmytrenko, L Greenberg, AL Bredemeyer, P Ma, J Liu, ... Basic to Translational Science 6 (4), 331-345, 2021 | 183 | 2021 |
| A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters TL Bricker, TL Darling, AO Hassan, HH Harastani, A Soung, X Jiang, ... Cell reports 36 (3), 2021 | 157 | 2021 |
| Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell M Puray-Chavez, KM LaPak, TP Schrank, JL Elliott, DP Bhatt, ... Cell Reports 36 (2), 2021 | 142 | 2021 |
| Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice AC Hunt, JB Case, YJ Park, L Cao, K Wu, AC Walls, Z Liu, JE Bowen, ... Science translational medicine 14 (646), eabn1252, 2022 | 100 | 2022 |
| Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance SE Hensley, SR Das, JS Gibbs, AL Bailey, LM Schmidt, JR Bennink, ... PLoS One 6 (2), e15190, 2011 | 96 | 2011 |
| GB virus C coinfections in west African Ebola patients M Lauck, AL Bailey, KG Andersen, TL Goldberg, PC Sabeti, DH O'Connor Journal of virology 89 (4), 2425-2429, 2015 | 88 | 2015 |
| High throughput detection of retrovirus-associated reverse transcriptase using an improved fluorescent product enhanced reverse transcriptase assay and its comparison to … A Lovatt, J Black, D Galbraith, I Doherty, MW Moran, AJ Shepherd, ... Journal of virological methods 82 (2), 185-200, 1999 | 87 | 1999 |
| Clinical microbiology is growing up: the total laboratory automation revolution AL Bailey, N Ledeboer, CAD Burnham Clinical chemistry 65 (5), 634-643, 2019 | 84 | 2019 |
| A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence X Zhang, Y Liu, J Liu, AL Bailey, KS Plante, JA Plante, J Zou, H Xia, ... Cell 184 (8), 2229-2238. e13, 2021 | 74 | 2021 |
| Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity JT Earnest, K Basore, V Roy, AL Bailey, D Wang, G Alter, DH Fremont, ... Journal of Experimental Medicine 216 (10), 2282-2301, 2019 | 73 | 2019 |
